Insulet (PODD) Stock Price, Quote, News & History | Benzinga

Insulet Corp (PODD) Stock Price, Quote, News & History

PODDNASDAQ

Trade with Public

Trade with Public

$163.26

4.883.08%

At close: Jul 24, 5:00 PM EST

$162.00

-1.26-0.77%

After Hours: 6:18 PM EST

OverviewNews Earnings Events Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$159.21

Close

$163.26

Volume / Avg.

1.15M / 1.60M

Day Range

$158.31 - $164.33

52 Wk Range

138.79 - 354.88

Market Cap

$11.40B

P/E Ratio

37.01

Dividend Yield

-

Exchange

NASDAQ

RSI

54

Short Interest

10.49%

Days to Cover

2.78

Recent Insulet Corp News

FDA Classifies Insulet Omnipod Recall as Serious After Injury Reports

FDA classified Insulet's Omnipod pod recall as Class I after reports of insulin under-delivery linked to 24 serious injuries.

Vandana Singh

This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page for full coverage.

Avi Kapoor

Nasdaq 100 Plunges Over 3% On Rate Hike Jitters, Bitcoin's Bloodbath Worsens: Stock Market Today

U.S. tech stocks plunged more than 3% by midday Friday after a hotter-than-expected jobs report fueled speculation that the Federal Reserve may raise interest rates later this year.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

619.30M

Investing Cash Flow (TTM)

-234.80M

Financing Cash Flow (TTM)

-1.19B

Free Cash Flow (TTM)

387.80M

Capital Expenditure (TTM)

-231.50M

Net Change in Cash (TTM)

-808.50M

Analyst Trends and Forecast

2

2

Apr

13

2

1

May

2

Jun

4

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$11.44B

PE Ratio (TTM)

37.01

PE Ratio (FWD)

25.51

PEG Ratio (TTM)

1.40

PS Ratio (TTM)

3.87

PB Ratio (TTM)

8.42

Earnings Yield % (TTM)

2.70%

Earnings Yield % (FWD)

3.92%

EV / EBITDA (TTM)

20.28

Price / EBITDA (TTM)

19.91

Price / Free Cash Flow (TTM)

28.96

Book Value / Share

$18.81

Company Debt

Total Debt

$948.10M

LT Debt

$929.50M

LT Debt Issuance (TTM)

$50.00M

LT Debt Repayment (TTM)

-$1.04B

Total Cash

$480.40M

Debt to Equity

0.73

Issuance of Debt (TTM)

-$986.10M

Repayment of Debt (TTM)

-$1.04B

Key Statistics

Open

$159.21

Close

$163.26

Volume / Avg.

1.15M / 1.60M

Day Range

$158.31 - $164.33

52 Wk Range

138.79 - 354.88

Market Cap

$11.40B

P/E Ratio

37.01

Dividend Yield

-

Exchange

NASDAQ

RSI

54

Short Interest

10.49%

Days to Cover

2.78

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated thro...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Insulet (PODD) stock?

A

You can purchase shares of Insulet (NASDAQ:PODD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Insulet (PODD) competitors?

A

There are no as such competitors for Insulet.

Q

What is the forecast, or price target, for Insulet (PODD) stock?

A

Insulet has a consensus price target of $279.75.

Q

What is the current price for Insulet (PODD)?

A

The stock price for Insulet (NASDAQ: PODD) is $162 last updated July 24, 2026 at 6:18 PM EDT.

Q

Does Insulet (PODD) pay a dividend?

A

There are no upcoming dividends for Insulet.

Q

When is Insulet (NASDAQ:PODD) reporting earnings?

A

Insulet does not have any upcoming earnings scheduled.

Q

Is Insulet (PODD) going to split?

A

There is no upcoming split for Insulet.

Q

What sector and industry does Insulet (PODD) operate in?

A

Insulet is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.